查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2030258

口服臨床營養市場－全球產業規模、佔有率、趨勢、機會、預測：按適應症、通路、地區和競爭格局分類，2021-2031年

Oral Clinical Nutrition Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication, By Distribution Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球口服臨床營養市場預計將從 2025 年的 169.6 億美元成長到 2031 年的 239.1 億美元，複合年成長率為 5.89%。

該領域專注於為食物攝取不足的患者提供專業的口服營養補充劑，例如患有疾病、疾病相關營養不良或處於術後恢復期的患者。市場成長的主要驅動力是全球需要特定營養干預的慢性疾病發生率不斷上升，包括糖尿病、癌症和胃腸道疾病。此外，全球人口老化加劇了老年人更容易出現與老齡化相關的營養不良，這顯著提升了產品需求；同時，醫療專業人員對營養在患者康復中的關鍵作用的認知不斷提高，也持續推動著市場的發展。

市場概覽
預測期 2027-2031
市場規模：2025年 169.6億美元
市場規模：2031年 239.1億美元
複合年成長率：2026-2031年 5.89%
成長最快的細分市場 慢性腎臟病
最大的市場 北美洲

儘管有這些正面趨勢，專業口服臨床營養產品的高昂成本和不完善的報銷體系仍然是市場成長的重大障礙，尤其是在開發中國家。這些經濟障礙往往限制了患者獲得必要的營養治療。一項發表在 ESPEN 2025 摘要中的研究凸顯了問題的嚴重性，該研究發現，53.2% 的篩檢患者患有營養不良，其餘 46.8% 的患者被歸類為存在營養不良風險。

市場促進因素

慢性病的日益增多是全球口服臨床營養市場的主要驅動力。糖尿病、癌症和胃腸道疾病等健康問題常常導致營養不良，因此迫切需要專業的營養治療來幫助患者康復並改善整體健康。口服臨床營養產品在解決疾病相關的營養不良方面發揮著至關重要的作用，它們能夠提供難以透過日常飲食獲得的必需營養素。美國臨床腫瘤學會（ASCO）2024年8月發布的一份報告也印證了這一巨大的需求，該報告指出，40%至80%的癌症患者存在營養不良，這表明全球慢性病的持續成長正在直接增加對有效口服營養治療的需求，而口服營養治療已成為綜合患者護理的核心組成部分。

隨著慢性病發病率的上升，全球老年人口也不斷成長，而老年人營養不良的風險是推動這一成長要素。隨著老齡化，老年人常常面臨食慾不振、吸收不良、牙齒問題和多種藥物依賴等併發症，這些都會導致營養缺乏。口服臨床營養補充品為滿足老年人的特定飲食需求、維持肌肉量、整體健康和生活品質提供了一個實用且有效的途徑。這一人群的需求規模龐大，聯合國人口司估計，到2025年7月，65歲以上人口將達到8.57億人。人口結構的變化以及人們對老年人營養不良問題的日益關注，顯著推動了產品需求的成長。根據《食品配料第一》2026年2月報道，達能特營養品部門2025年的同工同酬成長率為7.4%。

市場挑戰

專業口服臨床營養產品的高成本，加上難以預測的報銷政策，直接阻礙了全球口服臨床營養市場的擴張。這些經濟障礙嚴重限制了患者獲得必要的營養治療，尤其是在醫療資源極為匱乏的開發中國家。不斷上漲的自付費用和不足的醫療覆蓋範圍降低了這些必需製劑的使用率，導致患有特定疾病和營養不良的患者無法獲得他們康復所需的營養支持。

不同地區的報銷機制進一步加劇了這個難題。國際醫療營養產業協會 (MNI) 於 2026 年 2 月進行的一項調查顯示，雖然 90% 的受訪歐洲國家表示會為「特定醫用食品」提供某種形式的報銷，但患者實際獲得這些醫用營養產品的情況仍然不盡如人意。這種不一致凸顯了資金支持的分散性和不足性是市場滲透的直接障礙，限制了臨床口服營養療法的廣泛應用，儘管這些產品在臨床上有明確的需求。

市場趨勢

個人化飲食策略在全球口服臨床營養市場中發揮著至關重要的作用，其重點在於根據每位患者的基因組成、健康狀況和特定疾病狀態量身定製配方。這項轉變正推動產品從通用產品轉向旨在最大限度提高療效和患者依從性的客製化解決方案。這些個人化營養療法利用了更先進的診斷工具和對代謝功能的深入理解，使醫療專業人員能夠針對複雜疾病推薦精準的飲食方案。產業領導者達能公司報告稱，到2025年，其特種營養產品的銷售額將達到93億歐元，這充分體現了這一靶向營養領域的巨大規模。

電子商務和直接面對消費者（DTT）管道的快速成長是推動行業變革的另一個關鍵趨勢，其主要作用在於提升看護者和患者的便利性和產品可及性。這種分銷方式使製造商能夠將專業的臨床營養產品直接運送給終端用戶，為居住在偏遠地區或行動不便的人士帶來顯著優勢。此外，網路商店也為消費者提供全面的客戶服務和詳細的產品資訊。雀巢公司的數據清楚地展現了數位化購物加速發展的趨勢，該公司預計到2025年其電子商務銷售額將實現13.5%的年均內部成長，這反映出消費者正顯著轉向線上零售平台。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球口服臨床營養市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 適應症（阿茲海默症、營養不良、癌症照護、慢性腎臟病、吞嚥困難等）
    • 銷售管道細分（直接銷售與間接銷售）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美口服臨床營養市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲口服臨床營養市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區口服臨床營養市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲口服臨床營養市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲口服臨床營養市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球口服臨床營養市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Abbott Laboratories, Inc.
  • Pfizer, Inc.
  • Bayer AG
  • Nestle SA
  • GlaxoSmithKline plc
  • Baxter International Inc.
  • Otsuka Holdings, Co. Ltd.
  • Baxter International Inc.
  • Victus, Inc.
  • Danone SA

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 15208

The Global Oral Clinical Nutrition Market is anticipated to expand from USD 16.96 Billion in 2025 to USD 23.91 Billion by 2031, reflecting a compound annual growth rate of 5.89%. This sector involves specialized dietary formulations taken orally by patients suffering from poor dietary intake caused by medical ailments, disease-induced malnutrition, or post-operative healing. Market growth is primarily fueled by the rising global incidence of chronic illnesses, including diabetes, cancer, and gastrointestinal issues, which require specific nutritional interventions. Furthermore, an aging global population susceptible to age-induced nutritional shortfalls heavily drives product demand, while growing recognition among healthcare providers regarding the vital impact of nutrition on patient recovery continues to accelerate market momentum.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 16.96 Billion
Market Size 2031USD 23.91 Billion
CAGR 2026-20315.89%
Fastest Growing SegmentChronic Kidney Disease
Largest MarketNorth America

Despite this positive trajectory, a major hurdle to market growth remains the high expense of specialized oral clinical nutrition items, especially in developing nations, coupled with irregular reimbursement frameworks. Such financial barriers often limit patient accessibility to crucial nutritional therapies. Highlighting the scale of this issue, a study featured in the ESPEN 2025 abstract booklet revealed that 53.2% of screened patients suffered from malnutrition, while the remaining 46.8% were classified as being at risk.

Market Driver

The rising frequency of chronic illnesses acts as a primary catalyst for the Global Oral Clinical Nutrition Market. Health issues like diabetes, cancer, and gastrointestinal conditions often result in malnutrition, creating a critical need for specialized dietary solutions to aid patient recuperation and boost overall health outcomes. Oral clinical nutrition items play a vital role in addressing disease-associated malnutrition by delivering necessary nutrients that patients struggle to consume through standard diets. Underscoring this immense need, an August 2024 report from ASCO Publications noted that malnutrition affects 40 to 80% of cancer patients, proving that the steady global increase in chronic diseases directly amplifies the demand for effective oral nutritional therapies as a core element of comprehensive patient treatment.

Expanding alongside chronic illness is the global elderly population, which serves as another powerful growth driver due to its inherent malnutrition risks. As people age, they frequently encounter complications like diminished appetite, poor nutrient absorption, dental problems, and polypharmacy, all of which heighten their susceptibility to nutritional gaps. Oral clinical nutrition supplements provide a practical and efficient method to meet these unique dietary requirements, preserving muscle mass, overall health, and life quality for seniors. With the United Nations Population Division estimating the population aged 65 and older at 857 million as of July 2025, the scale of this demographic requirement is massive. This shifting age demographic and the rising awareness of elderly malnutrition are significantly propelling product demand, reflected in the 7.4% like-for-like growth reported in 2025 by Danone's Specialized Nutrition division, as noted by Food Ingredients First in February 2026.

Market Challenge

High expenses linked to specialized oral clinical nutrition items, combined with unpredictable reimbursement policies, create a direct obstacle to the expansion of the Global Oral Clinical Nutrition Market. These financial hurdles severely limit patient accessibility to vital nutritional treatments, most notably within developing nations where healthcare resources are tightly restricted. Elevated out-of-pocket costs and insufficient insurance coverage lower the utilization rates of these essential formulations, ultimately preventing individuals dealing with specific medical ailments or malnutrition from securing the dietary assistance they desperately require to recover.

Uneven reimbursement structures across various regions compound this difficult issue. A February 2026 survey by the Medical Nutrition International Industry (MNI) revealed that while 90% of participating European nations reported offering some degree of reimbursement for Foods for Special Medical Purposes, actual patient access to these medical nutrition products remains inadequately low. This inconsistency underscores how fragmented and deficient financial coverage serves as a direct roadblock, stifling market penetration and restricting the widespread availability of clinical oral nutrition therapies regardless of the clear clinical necessity for such products.

Market Trends

Customized dietary strategies are playing a major role in shaping the Global Oral Clinical Nutrition Market, emphasizing formulations that are specifically aligned with individual patient genetics, health profiles, and exact disease conditions. This transition shifts away from generic products in favor of bespoke solutions designed to maximize therapeutic benefits and improve patient compliance. These individualized nutritional treatments utilize improved diagnostic tools and a thorough comprehension of metabolic functions, allowing medical professionals to recommend precise diets for complicated illnesses. Highlighting the massive scale of this targeted nutrition sector, major industry player Danone recorded specialized nutrition sales reaching €9.3 billion in 2025.

The rapid growth of e-commerce and direct-to-consumer distribution channels stands as another crucial trend revolutionizing the industry, largely by improving convenience and product accessibility for both caregivers and patients. This distribution method permits manufacturers to ship specialized clinical nutrition items straight to end-users, offering a massive advantage to individuals living in isolated regions or those facing mobility issues. Furthermore, digital storefronts provide enhanced customer service and detailed product data to consumers. The escalating shift toward digital purchasing is clearly demonstrated by Nestle, which experienced a 13.5% organic increase in its e-commerce sales during 2025, reflecting a strong consumer pivot toward online retail platforms.

Key Market Players

  • Abbott Laboratories, Inc.
  • Pfizer, Inc.
  • Bayer AG
  • Nestle SA
  • GlaxoSmithKline plc
  • Baxter International Inc.
  • Otsuka Holdings, Co. Ltd.
  • Baxter International Inc.
  • Victus, Inc.
  • Danone SA

Report Scope

In this report, the Global Oral Clinical Nutrition Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oral Clinical Nutrition Market, By Indication

  • Alzheimer's
  • Nutritional Deficiencies
  • Cancer Care
  • Chronic Kidney Disease
  • Dysphagia
  • Others

Oral Clinical Nutrition Market, By Distribution Channel

  • Direct Sales
  • Indirect Sales

Oral Clinical Nutrition Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Oral Clinical Nutrition Market.

Available Customizations:

Global Oral Clinical Nutrition Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oral Clinical Nutrition Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Indication (Alzheimer's, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, Others)
    • 5.2.2. By Distribution Channel (Direct Sales v/s Indirect Sales)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Oral Clinical Nutrition Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Indication
    • 6.2.2. By Distribution Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Oral Clinical Nutrition Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Indication
        • 6.3.1.2.2. By Distribution Channel
    • 6.3.2. Canada Oral Clinical Nutrition Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Indication
        • 6.3.2.2.2. By Distribution Channel
    • 6.3.3. Mexico Oral Clinical Nutrition Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Indication
        • 6.3.3.2.2. By Distribution Channel

7. Europe Oral Clinical Nutrition Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Indication
    • 7.2.2. By Distribution Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Oral Clinical Nutrition Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Indication
        • 7.3.1.2.2. By Distribution Channel
    • 7.3.2. France Oral Clinical Nutrition Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Indication
        • 7.3.2.2.2. By Distribution Channel
    • 7.3.3. United Kingdom Oral Clinical Nutrition Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Indication
        • 7.3.3.2.2. By Distribution Channel
    • 7.3.4. Italy Oral Clinical Nutrition Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Indication
        • 7.3.4.2.2. By Distribution Channel
    • 7.3.5. Spain Oral Clinical Nutrition Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Indication
        • 7.3.5.2.2. By Distribution Channel

8. Asia Pacific Oral Clinical Nutrition Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Indication
    • 8.2.2. By Distribution Channel
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Oral Clinical Nutrition Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Indication
        • 8.3.1.2.2. By Distribution Channel
    • 8.3.2. India Oral Clinical Nutrition Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Indication
        • 8.3.2.2.2. By Distribution Channel
    • 8.3.3. Japan Oral Clinical Nutrition Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Indication
        • 8.3.3.2.2. By Distribution Channel
    • 8.3.4. South Korea Oral Clinical Nutrition Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Indication
        • 8.3.4.2.2. By Distribution Channel
    • 8.3.5. Australia Oral Clinical Nutrition Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Indication
        • 8.3.5.2.2. By Distribution Channel

9. Middle East & Africa Oral Clinical Nutrition Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Indication
    • 9.2.2. By Distribution Channel
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Oral Clinical Nutrition Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Indication
        • 9.3.1.2.2. By Distribution Channel
    • 9.3.2. UAE Oral Clinical Nutrition Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Indication
        • 9.3.2.2.2. By Distribution Channel
    • 9.3.3. South Africa Oral Clinical Nutrition Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Indication
        • 9.3.3.2.2. By Distribution Channel

10. South America Oral Clinical Nutrition Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Indication
    • 10.2.2. By Distribution Channel
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Oral Clinical Nutrition Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Indication
        • 10.3.1.2.2. By Distribution Channel
    • 10.3.2. Colombia Oral Clinical Nutrition Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Indication
        • 10.3.2.2.2. By Distribution Channel
    • 10.3.3. Argentina Oral Clinical Nutrition Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Indication
        • 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Oral Clinical Nutrition Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Pfizer, Inc.
  • 15.3. Bayer AG
  • 15.4. Nestle SA
  • 15.5. GlaxoSmithKline plc
  • 15.6. Baxter International Inc.
  • 15.7. Otsuka Holdings, Co. Ltd.
  • 15.8. Baxter International Inc.
  • 15.9. Victus, Inc.
  • 15.10. Danone SA

16. Strategic Recommendations

17. About Us & Disclaimer